Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12622000040763
ACTRN12622000040763
Completed
未知

The influence of the gut microbiome on resistance training-based skeletal muscle hypertrophy in healthy individuals.

Dr. Amanda Hagstrom0 sites64 target enrollmentJanuary 17, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsWhole-body lean massGut microbiome compositionGut microbiome diversityMusculoskeletal - Normal musculoskeletal and cartilage development and functionOral and Gastrointestinal - Normal oral and gastrointestinal development and function

Overview

Phase
未知
Intervention
Not specified
Conditions
Whole-body lean mass
Sponsor
Dr. Amanda Hagstrom
Enrollment
64
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 17, 2022
End Date
June 8, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr. Amanda Hagstrom

Eligibility Criteria

Inclusion Criteria

  • •1\. Men and women aged 18\-50
  • •2\. Body mass index (BMI) less than or equal to 25 (normal) because a BMI of greater than 25 has been shown to be associated with an altered gut microbiome.
  • •3\. Not meeting current physical activity guidelines of 150\-300 minutes of moderate intensity (50\-70% maximum heart rate) physical activity per week, measured with the IPAQ\-S.
  • •4\. No resistance training for at least 12 months prior..
  • •5\. Able to commit to three 1\-hour resistance exercise sessions per week for 12 weeks.

Exclusion Criteria

  • •1\. Antibiotic use within the previous eight weeks.
  • •2\. Cardiovascular, gastrointestinal, metabolic, or neuromuscular diseases, and musculoskeletal disease or injury.
  • •3\. Creatine supplementation within the previous eight weeks.
  • •4\. Pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The influence of the gut microbiome on immunity mediated by COVID-19 vaccinatiohealthy volunteers
DRKS00027050Institut für Prävention und Tumorepidemiologie143
Completed
Phase 1
Assessment of the influence of the gut microbiome on tacrolimus pharmacokinetics in healthy volunteersPharmacokinetic trial in healthy volunteers
DRKS00032072niversitätsklinikum Heidelberg, Im Wege der Auftragsverwaltung für die Universität Heidelberg, Medizinische Fakultät Heidelberg20
Recruiting
Not Applicable
Role of gut microbiome in epilepsy patientsHealth Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes
CTRI/2023/05/052680PGIMER Chandigarh
Completed
Not Applicable
The analysis of influences on the gut microbiota, the glycometabolism and the peritoneal permeability by the induction of dialysis and the peritonitis prevalence in peritoneal dialysis patients.end stage renal failure
JPRN-UMIN000014814Keio university school of medicine20
Completed
Not Applicable
Role of the immune system and the gut microbiota in neuroprotection: a dietary human intervention trialcardio metabolic risk
DRKS00015861Institut für Ernährungs- und Lebensmittelwissenschaften, Abteilung Ernährungsphysiologie, Rheinische Friedrich-Wilhelms-Universität Bonn120